Diagnostic options · UAE

Cancer Gene Panel tests in Dubai & UAE

Compare available Cancer Gene Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,500.00–4,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Gene Panel test prices

Showing 1–6 of 6 matching tests.

Cancer Gene Panel diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-517 Cancer 50 Gene Panel (NGS) Test This test identifies mutations in 50 genes linked to cancer development and progression.	Peripheral Blood (EDTA) or FFPE Tumour Tissue Block	10 working days	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants", "Small insertions and deletions", "Copy number alterations", "Variant allele frequency"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications without consulting your physician."] Indications ["Individuals with a personal or family history of cancer seeking targeted therapy guidance.", "Oncology patients requiring molecular profiling for treatment decisions.", "Asymptomatic individuals with a strong familial cancer pattern.", "Hematologic malignancies", "Solid neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 91847-2 ICD-10: Z12.89, C80.1 Clinical summary This test identifies mutations in 50 genes linked to cancer development and progression.
TEST-521 Cancer Gene Any 3 Markers NGS Test This test identifies pathogenic variants in three selected genes associated with hereditary cancer syndromes using next-generation sequencing.	Whole Blood (EDTA, Lavender Top) or FFPE Tissue Block	10 working days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels, CNVs) in three selected cancer susceptibility genes", "Analytical sensitivity for variant detection"] Parameters [] Preparation [] Indications ["Personal or family history suggestive of hereditary cancer syndrome", "Early-onset cancer diagnosis", "Multiple primary cancers", "Specific cancer types associated with hereditary syndromes (e.g., breast, ovarian, colorectal, prostate, pancreatic)"] Measurement technique Confirm with laboratory Codes LOINC: 92981-5 ICD-10: Z15.09 Clinical summary This test identifies pathogenic variants in three selected genes associated with hereditary cancer syndromes using next-generation sequencing.
TEST-537 Cancer Targeted Gene Panel (Lung) Test This test evaluates lung cancer tissue for specific genetic mutations, fusions, and copy number changes relevant to targeted therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides – Archival Specimen	10 working days	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Actionable mutations", "Fusions", "Copy number changes", "EGFR", "ALK", "ROS1", "KRAS", "BRAF"] Parameters [] Preparation ["No fasting required", "Ensure the NGS Requisition Form (Form 40) is completed"] Indications ["Diagnosis of lung cancer", "Guiding targeted therapy", "Guiding immunotherapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 75504-0 ICD-10: C34.9 Clinical summary This test evaluates lung cancer tissue for specific genetic mutations, fusions, and copy number changes relevant to targeted therapy.
TEST-528 Cancer Targeted Gene Panel: Lung with PD‑L1 (DAKO) Test This test evaluates key genetic mutations, rearrangements, and PD-L1 expression in lung cancer tissue.	Archival FFPE Tissue Block or Biopsy Slides	10–14 business days from receipt of adequate specimen	4,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Driver mutations (>50 key genes)", "Gene rearrangements", "PD-L1 tumour proportion score (TPS)"] Parameters [] Preparation [] Indications ["Diagnosis of non-small cell lung cancer (NSCLC)", "Guiding targeted therapy selection", "Guiding immunotherapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 96539-6 ICD-10: C34.9 Clinical summary This test evaluates key genetic mutations, rearrangements, and PD-L1 expression in lung cancer tissue.
TEST-1630 Endocrine Cancer Gene Panel Test This test evaluates for inherited mutations in genes associated with hereditary endocrine tumour syndromes using Next-Generation Sequencing (NGS).	Peripheral whole blood (EDTA tube)	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["≥30 genes associated with hereditary endocrine tumour syndromes", "Mutations in genes like MEN1, MEN2, RET, VHL"] Parameters [] Preparation ["No fasting required.", "Inform the phlebotomist of all medications and supplements."] Indications ["Individuals with a personal or family history suggestive of hereditary endocrine tumour syndromes.", "Screening for high-risk individuals based on family history.", "Diagnostic confirmation in suspected cases."] Measurement technique Confirm with laboratory Codes LOINC: 55233-5 ICD-10: Z15.04 Clinical summary This test evaluates for inherited mutations in genes associated with hereditary endocrine tumour syndromes using Next-Generation Sequencing (NGS).
TEST-1557 Gastro-Intestinal Cancer Gene Panel Test This test evaluates multiple genes associated with an increased risk of hereditary gastrointestinal cancers.	Peripheral Whole Blood	4–6 Weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Inherited mutations in genes linked to GI cancers"] Parameters [] Preparation ["Wait at least 2 weeks after acute infection or blood transfusion"] Indications ["Individuals with a personal or family history of gastrointestinal cancers", "Individuals with multiple primary cancers", "Individuals with early-onset cancer", "Individuals seeking to understand inherited cancer syndrome risks"] Measurement technique Confirm with laboratory Codes LOINC: 93035-9 ICD-10: Z15.09 Clinical summary This test evaluates multiple genes associated with an increased risk of hereditary gastrointestinal cancers.

Category overview

Cancer Gene Panel: overview

Confronting a complex family history of malignancies requires comprehensive clarity, giving you the foundation for a deeply proactive health strategy. Housed within our Molecular Diagnostics division, our advanced Cancer Gene Panel testing leverages high-throughput next-generation sequencing to simultaneously analyze a broad array of genes linked to hereditary cancer syndromes. Rather than acting as a definitive standalone diagnosis, this expansive cancer gene panel data empowers your oncology team with the critical molecular clarity required for highly customized, preventive medical guidance. Trusted as one of the most respected diagnostic labs in Dubai and the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality and exceptionally swift, accurate turnaround times. Empower your targeted prevention strategy: discover our cancer gene panel testing in the UAE below to book a test, schedule a seamless home sample collection, or consult our specialized experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.